HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Frazer Selected Research

APD791

6/2010Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Frazer Research Topics

Disease

1Thrombosis (Thrombus)
06/2010
1Substance-Related Disorders (Drug Abuse)
10/2006

Drug/Important Bio-Agent (IBA)

1APD791IBA
06/2010
1Serotonin (5 Hydroxytryptamine)IBA
06/2010
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
06/2010
1Opioid Analgesics (Opioids)IBA
10/2006